Product Information
CELLCEPT 250 MG CAPSULE is a brand product labeled by Genentech, Inc., priced at $8.6490 per EA under NDC 00004025943. Its NADAC has been published 384 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the Mycophenolate Mofetil market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
250 mg/1
Manufacturer
Genentech, Inc.NDC
00004025943
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
MYCOPHENOLATE MOFETILApproval Type
New Drug (NDA)
FDA Application
NDA050722On Market Since
5/3/1995
Pharmacological Classes
Price Statistics
The NADAC for CELLCEPT 250 MG CAPSULE has been published 384 times since Nov 28, 2013, and over the history we have for it it has risen 47.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.6490 per EA |
|---|---|
| All-time high | $8.7055 (Nov 13, 2024) |
| All-time low | $5.8526 (Nov 28, 2013) |
| 52-week high | $8.6795 |
| 52-week low | $8.6490 |
| Median price | $8.1504 |
| Average price | $7.8219 |
| Largest weekly change | +9.0% (Jan 14, 2015) |
| Weeks tracked | 384 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 98% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CELLCEPT 250 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CELLCEPT 250 MG CAPSULE, manufactured by Genentech, Inc., is $8.6490 per EA (NDC 00004025943), effective Jun 24, 2026.
How has the price of CELLCEPT 250 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CELLCEPT 250 MG CAPSULE has risen 47.8%. It has been tracked across 384 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CELLCEPT 250 MG CAPSULE?
Since Nov 28, 2013, the NADAC for CELLCEPT 250 MG CAPSULE has ranged from a low of $5.8526 (Nov 28, 2013) to a high of $8.7055 (Nov 13, 2024), with a median of $8.1504 per EA.
Are there cheaper alternatives to CELLCEPT 250 MG CAPSULE?
Yes. 6 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, MYCOPHENOLATE 250 MG CAPSULE, is $0.1387 per EA — about 98% below CELLCEPT 250 MG CAPSULE.
Who manufactures CELLCEPT 250 MG CAPSULE?
CELLCEPT 250 MG CAPSULE (NDC 00004025943) is labeled by Genentech, Inc., and CMS classifies it as a brand product.